Pitch 1-8 : Yasumichi Hitoshi, Thyas Co. Ltd.
Fighting Cancer with Nobel Prize-winning iPS Cell Technology
President & CEO, Thyas Co. Ltd.
等 泰道 氏
|Speaker Profile||Dr. Hitoshi obtained a MD degree and acquired PhD in immunology. He is familiar with immunology, cytokine signaling, immuno-oncology, cancer metabolism, metabolic diseases, and retroviral transduction systems. He has >15 year experience with heading oncology and metabolism researches (Target identification and validation, preclinical development of small molecule therapeutics) as a research director. He was involved in the IND filling process of multiple drugs.|
HVC KYOTO 2018 will be held on July 3rd 2018!
Click here for the program.
To attend the event, please fill out the form from here!
HVC KYOTO 2018は2018/7/3に開催いたします。
当日のプログラムは こちら をご覧ください。
HVC KYOTO 2018への参加お申し込みは こちら から。